U.S. regulators have expanded the use of pharmaceutical company Merck’s cervical cancer vaccine to adults up to age 45, according to a new report from The Associated Press.
Black News, Commentary and Culture | The Washington Informer
U.S. regulators have expanded the use of pharmaceutical company Merck’s cervical cancer vaccine to adults up to age 45, according to a new report from The Associated Press.
